ENG and recessive dystrophic epidermolysis bullosa: Raloxifene, NAC and losartan each increased the amount of soluble endoglin detected in the fibroblasts from the three RDEB patients by three to 10-fold, a direct reflection of the increase in membrane endoglin (Figure 1A,B).